Triathlete receives sanction
Sport Integrity Australia acknowledges the decision of Sport Ireland to sanction athlete Ben Shaw for the presence of a metabolite of a prohibited substance.
Mr Shaw returned an Adverse Analytical Finding (AAF) from an out-of-competition doping control test on 22 July 2020.
His sample detected the presence of Di-Hydroxy LGD-4033 (metabolite of LGD-4033). LGD-4033 is prohibited in and out-of-competition under the S1 Class of Anabolic Agents.
- Sport Ireland imposed a four-year ban on Mr Shaw commencing on 22 July 2020.
- Mr Shaw will be eligible to return to competition on 22 July 2024.
Additional information on the prohibited substance
LGD-4033, originally developed for the treatment of muscle wasting conditions such as aging, osteoporosis, muscular dystrophy and cancer, is promoted as a selective non-steroidal anabolic agent.
It is claimed to be a substance that induces muscle (and bone) growth without the side effects associated with steroid use. However, information on the safety of LGD-4033 is scarce due to a lack of medium and long-term clinical trials - hence the medium and long-term health impacts are unknown.
It should be noted that a number of Selective Androgen Receptor Modulators (SARMs) have associated health-risks, particularly for the heart and liver.
Sport Integrity Australia is committed to protecting the right of clean athletes to fair competition.
If you are aware of any suspicious doping activity, you can:
Sport Integrity Australia recommends athletes check substances and medications before taking them and to follow our advice on any sport supplements.
The Sport Integrity app provides a useful resource for athletes and support staff to check substances and medications. Additionally, it provides information on how to find batch-tested supplements or see if a Therapeutic Use Exemption (TUE) is required.